Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Melody SmithAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAAnqi DaiAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAGuido GhilardiCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAKimberly V. AmelsbergCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USASean M. DevlinDepartment of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USARaymone PajarilloDivision of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USAJohn SlingerlandAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USASilvia BeghiDepartment of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USAPamela S. HerreraAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAPaul A. GiardinaAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAAnnelie ClurmanAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAEmmanuel Agyemang DwomohAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAGabriel K. ArmijoAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAAntonio L. C. GomesAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAEric R. LittmannThe Duchossois Family Institute, University of Chicago, Chicago, IL, USAJonas SchlüterInstitute for Computational Medicine, New York University Langone Health, New York, NY, USAEmily FontanaMolecular Microbiology Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USAYing TaurInfectious Disease Service, Department of Medicine, and Immunology Program, Sloan Kettering Institute, New York, NY, USAJae H. ParkCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAMaria Lia PalombaCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAElizabeth HaltonCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAJosel D. RuizAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USATania JainDivision of Hematologic Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USAMartina PennisiDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, ItalyAishat Olaide AfuyeAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAMiguel‐Angel PeralesAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USACraig W. FreyerDepartment of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USAAlfred L. GarfallCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAShannon GierCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USASunita D. NastaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USADaniel J. LandsburgCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAJames N. GersonCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAJakub SvobodaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAJustin R. CrossThe Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY, USAElise A. ChongCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USASergio GiraltAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USASaar GillCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAIsabelle RivièreCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USADavid L. PorterCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAStephen J. SchusterCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAMichel SadelainCenter for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USANoelle V. FreyCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USARenier J. BrentjensCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USACarl H. JuneCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USAEric G. PamerThe Duchossois Family Institute, University of Chicago, Chicago, IL, USAJonathan U. PeledAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAAndrea FacciabeneCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA. [email protected]Marcel R.M. van den BrinkAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. [email protected]Marco RuellaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA. [email protected]
2022en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0